HIV/AIDS

Trending: FDA Advisory Panel Says Benefits of Painkiller Opana ER No Longer Outweigh Risks

  • Trending story detected by Trendolizer™

FDA Advisory Panel Says Benefits of Painkiller Opana ER No Longer Outweigh Risks

The benefits of an opioid painkiller linked to a 2015 HIV outbreak in Indiana no longer outweigh the risks, a panel of advisers to the U.S. Food and Drug Administration concluded Tuesday.
Read the full story at: www.wsj.com

More news

Trendolizer™ Trending News Tracker

FREE: Get the most trending items found on the web by Trendolizer™ delivered to your inbox weekly

Most read

Recent

Like or Follow us to get the latest!

Latest Trending News

    Recent in HIV/AIDS